Canopy Growth (CGC) Total Non-Current Liabilities (2017 - 2025)

Canopy Growth's (CGC) quarterly Total Non-Current Liabilities came in at $231.8 million in Q4 2025, down 44.22% year-on-year from $415.6 million in Q4 2024, and up 3.77% quarter-over-quarter from $223.4 million in Q3 2025.

Canopy Growth (CGC) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends

Canopy Growth has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $231.8 million for Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $231.8 million, down 44.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $231.8 million (down 44.22% YoY), and the FY2025 annual result was $274.7 million, down 49.15% from the prior year.
  • Total Non-Current Liabilities came in at $231.8 million for Q4 2025 at Canopy Growth, up from $223.4 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.4 billion in Q1 2021 to a low of $223.4 million in Q3 2025.
  • The 5-year median for Total Non-Current Liabilities is $772.6 million (2023), against an average of $960.1 million.
  • Across the five-year window, Total Non-Current Liabilities surged 122450.02% in 2021 and sank 56.29% in 2025, its largest moves.
  • Canopy Growth's Total Non-Current Liabilities stood at $1.5 billion in 2021, then decreased by 24.76% to $1.1 billion in 2022, then tumbled by 51.98% to $545.1 million in 2023, then declined by 23.76% to $415.6 million in 2024, then sank by 44.22% to $231.8 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $231.8 million (Q4 2025), $223.4 million (Q3 2025), and $279.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Canopy Growth 11.38 Mn -137.31 Mn 15.39 Mn 231.82 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 231.82 Mn
Sep 30, 2025 223.39 Mn
Jun 30, 2025 279.78 Mn
Mar 31, 2025 274.73 Mn
Dec 31, 2024 415.58 Mn
Sep 30, 2024 511.10 Mn
Jun 30, 2024 530.14 Mn
Mar 31, 2024 540.27 Mn
Dec 31, 2023 545.09 Mn
Sep 30, 2023 618.71 Mn
Jun 30, 2023 926.46 Mn
Mar 31, 2023 1.21 Bn
Dec 31, 2022 1.14 Bn
Sep 30, 2022 1.23 Bn
Jun 30, 2022 1.42 Bn
Mar 31, 2022 1.42 Bn
Dec 31, 2021 1.51 Bn
Sep 30, 2021 1.64 Bn
Jun 30, 2021 2.10 Bn
Mar 31, 2021 2.44 Bn